Skip to main content

Articles

Page 74 of 85

  1. Most studies on intracoronary bone marrow mononuclear cell transplantation for acute myocardial infarction involve treatment 3–7 days after primary percutaneous coronary intervention (PCI); however, the optima...

    Authors: Rongchong Huang, Kang Yao, Aijun Sun, Juying Qian, Lei Ge, Yiqi Zhang, Yuhong Niu, Keqiang Wang, Yunzeng Zou and Junbo Ge
    Citation: Stem Cell Research & Therapy 2015 6:112
  2. The release of trophic factors from mesenchymal stem cells (MSCs) is critical for tissue regeneration. A systematic investigation of the regenerative potential of trophic factors from different MSCs, however, ...

    Authors: Y Hayashi, M Murakami, R Kawamura, R Ishizaka, O Fukuta and M Nakashima
    Citation: Stem Cell Research & Therapy 2015 6:111

    The Erratum to this article has been published in Stem Cell Research & Therapy 2016 7:86

  3. Stem cell therapy with bone marrow-derived mononuclear cells (BMMCs) is an option for improving joint function in osteonecrosis of the femoral head (ONFH). Bone marrow-derived mesenchymal stromal cell (MSC) nu...

    Authors: Gildasio Cerqueira Daltro, Vitor Fortuna, Eliane Silva de Souza, Marcela Miranda Salles, Ana Claudia Carreira, Roberto Meyer, Songeli Menezes Freire and Radovan Borojevic
    Citation: Stem Cell Research & Therapy 2015 6:110
  4. Engineered bioimplants for cardiac repair require functional vascularization and innervation for proper integration with the surrounding myocardium. The aim of this work was to study nerve sprouting and neovas...

    Authors: Carolina Gálvez-Montón, M. Teresa Fernandez-Figueras, Mercè Martí, Carolina Soler-Botija, Santiago Roura, Isaac Perea-Gil, Cristina Prat-Vidal, Aida Llucià-Valldeperas, Ángel Raya and Antoni Bayes-Genis
    Citation: Stem Cell Research & Therapy 2015 6:108
  5. Severe spinal cord injury often causes temporary or permanent damages in strength, sensation, or autonomic functions below the site of the injury. So far, there is still no effective treatment for spinal cord ...

    Authors: Xue-Cheng Qiu, Hui Jin, Rong-Yi Zhang, Ying Ding, Xiang Zeng, Bi-Qin Lai, Eng-Ang Ling, Jin-Lang Wu and Yuan-Shan Zeng
    Citation: Stem Cell Research & Therapy 2015 6:105
  6. Secondary osteoporosis is common in systemic lupus erythematosus and leads to a reduction in quality of life due to fragility fractures, even in patients with improvement of the primary disorder. Systemic tran...

    Authors: Lan Ma, Reona Aijima, Yoshihiro Hoshino, Haruyoshi Yamaza, Erika Tomoda, Yosuke Tanaka, Soichiro Sonoda, Guangtai Song, Wei Zhao, Kazuaki Nonaka, Songtao Shi and Takayoshi Yamaza
    Citation: Stem Cell Research & Therapy 2015 6:104
  7. Stem cell behaviors are regulated by multiple microenvironmental cues. As an external signal, mechanical stiffness of the extracellular matrix is capable of governing stem cell fate determination, but how this...

    Authors: Hongwei Lv, Lisha Li, Meiyu Sun, Yin Zhang, Li Chen, Yue Rong and Yulin Li
    Citation: Stem Cell Research & Therapy 2015 6:103
  8. Malaria is the most relevant parasitic disease worldwide, and still accounts for 1 million deaths each year. Since current antimalarial drugs are unable to prevent death in severe cases, new therapeutic strate...

    Authors: Mariana C Souza, Johnatas D Silva, Tatiana A Pádua, Natália D Torres, Mariana A Antunes, Debora G Xisto, Thiago P Abreu, Vera L Capelozzi, Marcelo M Morales, Ana A. Sá Pinheiro, Celso Caruso-Neves, Maria G Henriques and Patricia RM Rocco
    Citation: Stem Cell Research & Therapy 2015 6:102
  9. The purpose of this study was to investigate the expression of Wnt and Notch signaling pathway-related genes in inflammatory bowel disease (IBD) treated with mesenchymal stem cell transplantation (MSCT).

    Authors: Yanfen Xing, Xiaojie Chen, Yanwen Cao, Jianyun Huang, Xuhong Xie and Yaming Wei
    Citation: Stem Cell Research & Therapy 2015 6:101
  10. Mesenchymal stem cells (MSCs) play a central role in the remediation of cell and tissue damage. Erythropoietin (EPO) may enhance the beneficial influence of MSCs during recovery from tissue and organ injuries....

    Authors: Yan Wang, Xingyan Lu, Juan He and Weihong Zhao
    Citation: Stem Cell Research & Therapy 2015 6:100
  11. Osteopontin (OPN) is a phosphoglycoprotein with important roles in tissue homeostasis, wound healing, immune regulation, and stress responses. It is expressed constitutively in the brain and upregulated during...

    Authors: Monika Rabenstein, Joerg Hucklenbroich, Antje Willuweit, Anne Ladwig, Gereon Rudolf Fink, Michael Schroeter, Karl-Josef Langen and Maria Adele Rueger
    Citation: Stem Cell Research & Therapy 2015 6:99
  12. Fallopian tube, which is normally discarded in surgical procedures, has proven to be a source of mesenchymal stem cells (MSCs) with increasing evidence. However, fallopian tube mucosa, which can be acquired vi...

    Authors: Jiaojiao Wang, Yong Zhao, Xiaoyun Wu, Shande Yin, Yunhai Chuai and Aiming Wang
    Citation: Stem Cell Research & Therapy 2015 6:98
  13. Idiopathic pulmonary fibrosis is a progressive diffuse parenchymal lung disorder of unknown etiology. Mesenchymal stem cell (MSC)-based therapy is a novel approach with great therapeutic potential for the trea...

    Authors: Ying-Wei Lan, Kong-Bung Choo, Chuan-Mu Chen, Tsai-Hsien Hung, Young-Bin Chen, Chung-Hsing Hsieh, Han-Pin Kuo and Kowit-Yu Chong
    Citation: Stem Cell Research & Therapy 2015 6:97
  14. Mouse pancreas has a remarkable ability to regenerate after partial pancreatectomy, and several investigators have studied the underlying mechanisms involved in this regeneration process; however, the field re...

    Authors: Deepa Bhartiya and Hiren Patel
    Citation: Stem Cell Research & Therapy 2015 6:96
  15. Adipose-derived stem cells (ADSC) are non-hematopoietic mesenchymal stem cells that have shown great promise in their ability to differentiate into multiple cell lineages. Their ubiquitous nature and the ease ...

    Authors: Haitao Shen, Enchen Zhou, Xiujing Wei, Zhiwei Fu, Chenguang Niu, Yang Li, Bing Pan, Anna V Mathew, Xu Wang, Subramaniam Pennathur, Lemin Zheng and Yongyu Wang
    Citation: Stem Cell Research & Therapy 2015 6:95
  16. The evolution of articular cartilage repair procedures has resulted in a variety of cell-based therapies that use both autologous and allogeneic mesenchymal stromal cells (MSCs). As these cells are increasingl...

    Authors: Lucienne A. Vonk, Tommy S. de Windt, Ineke C. M. Slaper-Cortenbach and Daniël B. F. Saris
    Citation: Stem Cell Research & Therapy 2015 6:94
  17. Diffuse axonal injury is an extremely common type of traumatic brain injury encountered in motor vehicle crashes, sports injuries, and in combat. Although many cases of diffuse axonal injury result in chronic ...

    Authors: Leyan Xu, Jiwon Ryu, Hakim Hiel, Adarsh Menon, Ayushi Aggarwal, Elizabeth Rha, Vasiliki Mahairaki, Brian J Cummings and Vassilis E Koliatsos
    Citation: Stem Cell Research & Therapy 2015 6:93
  18. Growing evidence has brought stem cell therapy to the forefront as new promising approaches towards stroke treatment. Of all candidate seeding cells, adipose-derived stem cells (ADSCs) are considered as one of...

    Authors: Fei Zhou, Shane Gao, Lin Wang, Chenxi Sun, Lu Chen, Ping Yuan, Haiyang Zhao, Yi Yi, Ying Qin, Zhiqiang Dong, Limei Cao, Haiyan Ren, Liang Zhu, Qiang Li, Bing Lu, Aibin Liang…
    Citation: Stem Cell Research & Therapy 2015 6:92

    The Correction to this article has been published in Stem Cell Research & Therapy 2019 10:76

  19. Transplantation of bone marrow mesenchymal stem cells (BMSCs) can repair injured hearts. However, whether BMSC populations contain cells with cardiac stem cell characteristics is ill-defined. We report here th...

    Authors: Ranran Ding, Xiaofan Jiang, Yanping Ha, Zhenliang Wang, Junli Guo, Hanguo Jiang, Shaojiang Zheng, Zhihua Shen and Wei Jie
    Citation: Stem Cell Research & Therapy 2015 6:91
  20. The secretion of trophic factors by mesenchymal stromal cells has gained increased interest given the benefits it may bring to the treatment of a variety of traumatic injuries such as skin wounds. Herein, we r...

    Authors: Jorge M Santos, Sérgio P Camões, Elysse Filipe, Madalena Cipriano, Rita N Barcia, Mariana Filipe, Mariana Teixeira, Sandra Simões, Manuela Gaspar, Diogo Mosqueira, Diana S Nascimento, Perpétua Pinto-do-Ó, Pedro Cruz, Helder Cruz, Matilde Castro and Joana P Miranda
    Citation: Stem Cell Research & Therapy 2015 6:90
  21. Advances in tendon engineering with mesenchymal stem cells (MSCs) are hindered by a need for cues to direct tenogenesis, and markers to assess tenogenic state. We examined the effects of factors involved in em...

    Authors: Jeffrey P Brown, Thomas V Galassi, Matteo Stoppato, Nathan R Schiele and Catherine K Kuo
    Citation: Stem Cell Research & Therapy 2015 6:89
  22. Human mesenchymal stem cells (hMSCs) reside in a perivascular niche of the body, suggesting that they interact closely with vascular endothelial cells (ECs) through cell-cell interaction or paracrine signaling...

    Authors: Tsung-Lin Tsai, Bowen Wang, Matthew W Squire, Lian-Wang Guo and Wan-Ju Li
    Citation: Stem Cell Research & Therapy 2015 6:88
  23. Breast cancer progression is promoted by stromal cells that populate the tumors, including cancer-associated fibroblasts (CAFs) and mesenchymal stem/stromal cells (MSCs). The activities of CAFs and MSCs in bre...

    Authors: Christina Katanov, Shalom Lerrer, Yulia Liubomirski, Leonor Leider-Trejo, Tsipi Meshel, Jair Bar, Rotem Feniger-Barish, Iris Kamer, Gali Soria-Artzi, Hadar Kahani, Debabrata Banerjee and Adit Ben-Baruch
    Citation: Stem Cell Research & Therapy 2015 6:87
  24. Skin as the largest and easily accessible organ of the body represents an abundant source of adult stem cells. Among them, dermal stem cells hold great promise in tissue repair and the skin granulation tissue ...

    Authors: Zelin Chen, Tingyu Dai, Xia Chen, Li Tan and Chunmeng Shi
    Citation: Stem Cell Research & Therapy 2015 6:85
  25. The quality of cartilaginous tissue derived from bone marrow mesenchymal stromal stem cell (BMSC) transplantation has been correlated with clinical outcome. Therefore, culture conditions capable of modulating ...

    Authors: Troy D Bornes, Nadr M Jomha, Aillette Mulet-Sierra and Adetola B Adesida
    Citation: Stem Cell Research & Therapy 2015 6:84
  26. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial repair. While their functional and structural properties have been extensively investigated, their response to isch...

    Authors: Andreja Brodarac, Tomo Šarić, Barbara Oberwallner, Shokoufeh Mahmoodzadeh, Klaus Neef, Julie Albrecht, Karsten Burkert, Matteo Oliverio, Filomain Nguemo, Yeong-Hoon Choi, Wolfram F Neiss, Ingo Morano, Jürgen Hescheler and Christof Stamm
    Citation: Stem Cell Research & Therapy 2015 6:83
  27. Mesenchymal stem cells (MSCs)-based therapies have had positive outcomes in animal models of cardiovascular diseases. However, the number and function of MSCs decline with age, reducing their ability to contri...

    Authors: Wenzheng Xia, Fengyun Zhang, Congying Xie, Miaomiao Jiang and Meng Hou
    Citation: Stem Cell Research & Therapy 2015 6:82
  28. Osteosarcoma is the most common primary malignant bone tumor, and the grading of osteosarcoma cells relies on traditional histopathology and molecular biology methods, which require RNA extraction, protein iso...

    Authors: Yi-Hung Chiang, Stewart H Wu, Yi-Chun Kuo, How-Foo Chen, Arthur Chiou and Oscar K Lee
    Citation: Stem Cell Research & Therapy 2015 6:81
  29. Deciduous and permanent human teeth represent an excellent model system to study aging of stromal populations. Aging is tightly connected to self-renewal and proliferation and thus, mapping potential molecular...

    Authors: Nina Kaukua, Mo Chen, Paolo Guarnieri, Markus Dahl, Mei Ling Lim, Tülay Yucel-Lindberg, Erik Sundström, Igor Adameyko, Jeremy J Mao and Kaj Fried
    Citation: Stem Cell Research & Therapy 2015 6:59
  30. A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all or to ...

    Authors: Pellegrino Musto, Vittorio Simeon, Alberto Grossi, Francesca Gay, Sara Bringhen, Alessandra Larocca, Roberto Guariglia, Giuseppe Pietrantuono, Oreste Villani, Giovanni D’Arena, Carmela Cuomo, Clelia Musto, Fortunato Morabito, Maria Teresa Petrucci, Massimo Offidani, Elena Zamagni…
    Citation: Stem Cell Research & Therapy 2015 6:64
  31. Transplantation of endothelial progenitor cells (EPCs) restores endothelial function in patients with endothelial dysfunction and initial denudation. The goal of the present study was to determine the effect o...

    Authors: Yangguang Yin, Huanyun Liu, Fangjuan Wang, Lufeng Li, Mengyang Deng, Lan Huang and Xiaohui Zhao
    Citation: Stem Cell Research & Therapy 2015 6:37
  32. Implantation of mesenchymal stem cells (MSCs) has recently been reported to repair tissue injuries through anti-inflammatory and immunosuppressive effects. We established dedifferentiated fat (DFAT) cells that...

    Authors: Takashi Maruyama, Noboru Fukuda, Taro Matsumoto, Koichiro Kano, Morito Endo, Minako Kazama, Tomohiko Kazama, Jin Ikeda, Hiroyuki Matsuda, Takahiro Ueno, Masanori Abe, Kazuyoshi Okada, Masayoshi Soma, Koichi Matsumoto and Hiroshi Kawachi
    Citation: Stem Cell Research & Therapy 2015 6:80
  33. Inflammatory bowel diseases (IBD) are complex multi-factorial diseases with increasing incidence worldwide but their treatment is far from satisfactory. Unconventional strategies have consequently been investi...

    Authors: Antara Banerjee, Debora Bizzaro, Patrizia Burra, Rosa Di Liddo, Surajit Pathak, Diletta Arcidiacono, Andrea Cappon, Patrizio Bo, Maria Teresa Conconi, Marika Crescenzi, Claudia Maria Assunta Pinna, Pier Paolo Parnigotto, Malcolm R Alison, Giacomo Carlo Sturniolo, Renata D’Incà and Francesco Paolo Russo
    Citation: Stem Cell Research & Therapy 2015 6:79
  34. Macrophage-driven inflammation is a key feature of the early period following tendon repair, but excessive inflammation has been associated with poor clinical outcomes. Modulation of the inflammatory environme...

    Authors: Cionne N Manning, Catherine Martel, Shelly E Sakiyama-Elbert, Matthew J Silva, Shivam Shah, Richard H Gelberman and Stavros Thomopoulos
    Citation: Stem Cell Research & Therapy 2015 6:74
  35. Paracrine effects can be exploited in cell-based therapies that secrete factors, such as chemokines and cytokines, and can recruit inflammatory cells to transplants. In this study, mouse adipose tissue-derived...

    Authors: Hidemi Hattori and Masayuki Ishihara
    Citation: Stem Cell Research & Therapy 2015 6:70
  36. Recent studies in the literature have highlighted the critical role played by cell signalling in determining haemopoietic stem cell (HSC) fate within ex vivo culture systems. Stimulatory signals can enhance proli...

    Authors: Joseph D Berry, Pankaj Godara, Petar Liovic and David N Haylock
    Citation: Stem Cell Research & Therapy 2015 6:58
  37. Mesenchymal stem cells (MSCs) have the ability to proliferate in vivo with a large variety of differentiation potentials and therefore are widely used as an ideal material for cell therapy. MSCs derived from pig ...

    Authors: Lei Huang, Chenguang Niu, Belinda Willard, Weimin Zhao, Lan Liu, Wei He, Tianwen Wu, Shulin Yang, Shutang Feng, Yulian Mu, Lemin Zheng and Kui Li
    Citation: Stem Cell Research & Therapy 2015 6:77
  38. Intravenous (IV) injection of mesenchymal stem cells (MSCs) is used to treat systemic human diseases and disorders but is not routinely used in equine therapy. In horses, MSCs are isolated primarily from adipo...

    Authors: Amir Kol, Joshua A Wood, Danielle D Carrade Holt, Jessica A Gillette, Laurie K Bohannon-Worsley, Sarah M Puchalski, Naomi J Walker, Kaitlin C Clark, Johanna L Watson and Dori L Borjesson
    Citation: Stem Cell Research & Therapy 2015 6:73
  39. Healthy bone marrow cell (BMC) infusion improves renal function and limits renal injury in a model of chronic kidney disease (CKD) in rats. However, BMCs derived from rats with CKD fail to retain beneficial ef...

    Authors: Arianne van Koppen, Diana A Papazova, Nynke R Oosterhuis, Hendrik Gremmels, Rachel H Giles, Joost O Fledderus, Jaap A Joles and Marianne C Verhaar
    Citation: Stem Cell Research & Therapy 2015 6:63
  40. The preliminary results of ovarian transplantation in clinical practice are encouraging. However, the follicular depletion caused by ischemic injury is a main concern and is directly related to short-term graf...

    Authors: Luciana Lamarão Damous, Juliana Sanajotti Nakamuta, Ana Elisa Teófilo Saturi de Carvalho, José Maria Soares-Jr, Manuel de Jesus Simões, José Eduardo Krieger and Edmund C Baracat
    Citation: Stem Cell Research & Therapy 2015 6:57
  41. Human adipose tissue-derived stem cells (hASCs) are attractive cells for therapeutic applications and are currently being evaluated in multiple clinical trials. Prior to their clinical application, hASCs must ...

    Authors: Ana CC Paula, Thaís MM Martins, Alessandra Zonari, Soraia PPJ Frade, Patrícia C Angelo, Dawidson A Gomes and Alfredo M Goes
    Citation: Stem Cell Research & Therapy 2015 6:76
  42. Growing recognition of paracrine mechanisms in stem cell plasticity has resulted in considerable interest in stem cell-derived secretome. The aim of this study was to investigate the effects of lipopolysacchar...

    Authors: Sang Chul Lee, Hye Jin Jeong, Sang Kuon Lee and Say-June Kim
    Citation: Stem Cell Research & Therapy 2015 6:75
  43. Subcutaneous adipose tissue is an interesting source of autologous stem cells with a fundamental role in the pathophysiology of obesity, metabolic syndromes and insulin resistance. We hypothesize that obesity ...

    Authors: Karina R Silva, Sally Liechocki, João R Carneiro, Cesar Claudio-da-Silva, Clarissa M Maya-Monteiro, Radovan Borojevic and Leandra S Baptista
    Citation: Stem Cell Research & Therapy 2015 6:72
  44. Human parthenogenetic embryonic stem cells (hpESCs) are generated from artificially activated oocytes, however, the issue of whether hpESCs have equivalent differentiation ability to human fertilized embryonic...

    Authors: Yang Yu, Qian Gao, Hong-cui Zhao, Rong Li, Jiang-man Gao, Ting Ding, Si-yu Bao, Yue Zhao, Xiao-fang Sun, Yong Fan and Jie Qiao
    Citation: Stem Cell Research & Therapy 2015 6:69

    The Erratum to this article has been published in Stem Cell Research & Therapy 2015 6:180

  45. Mesenchymal progenitor cells interact with immune cells and modulate inflammatory responses. The cellular characteristics required for this modulation are under fervent investigation. Upon interaction with mac...

    Authors: Jodi F Evans, Veronica Salvador, Sheela George, Cristina Trevino-Gutierrez and Catherine Nunez
    Citation: Stem Cell Research & Therapy 2015 6:56
  46. Osteonecrosis of the femoral head (ONFH) is a degenerative disease progressing to a femoral head (FH) collapse. Injection of osteoprogenitor cells like bone marrow mesenchymal stromal cells (BMSCs) into the FH...

    Authors: Angélique Lebouvier, Alexandre Poignard, Madeleine Cavet, Jérôme Amiaud, Julie Leotot, Philippe Hernigou, Alain Rahmouni, Philippe Bierling, Pierre Layrolle, Hélène Rouard and Nathalie Chevallier
    Citation: Stem Cell Research & Therapy 2015 6:68
  47. Stimulation of mesenchymal stromal cells and adipose tissue-derived stromal cells (ASCs) with vascular endothelial growth factor (VEGF) has been used in multiple animal studies and clinical trials for regenera...

    Authors: Josefine Tratwal, Anders Bruun Mathiasen, Morten Juhl, Sonja Kim Brorsen, Jens Kastrup and Annette Ekblond
    Citation: Stem Cell Research & Therapy 2015 6:62
  48. Mesenchymal stem cells (MSCs) are promising candidates for cell-based therapies. Human platelet lysate represents an efficient alternative to fetal bovine serum for clinical-scale expansion of MSCs. Different ...

    Authors: Chun-yu Li, Xiao-yun Wu, Jia-bei Tong, Xin-xin Yang, Jing-li Zhao, Quan-fu Zheng, Guo-bin Zhao and Zhi-jie Ma
    Citation: Stem Cell Research & Therapy 2015 6:55

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    211 days submission to accept (Median)

    2023 Usage 
    3,320,811 downloads
    1,402 Altmetric mentions